These N-glycans can be responsible for (1) the adhesion of cancer cells to T cells or stimulated lymphocytes expressing IL-2Rbeta; (2) an interference with the IL-2-dependent activation processes; and (3) a trapping of circulating IL-2. The gene discussed is IL2; the disease is cancer.